Agent Capital Investor

Agent Capital is a biotech venture capital firm focused on investing in novel therapeutics that address unmet patient need. Balanced two-pronged approach, between clinical stage companies with high commercial potential and early-stage transformative technologies prime for future M&A. From preclinical to commercial stage, Agent Capital makes direct equity investments across all stages of development. Agent Capital's team partners with scientists, entrepreneurs and other investors to develop the next generation of healthcare innovations, focusing on making a difference in patients’ lives.

Invests into
Technology: Researching Mechanisms of Disease
Industry: Regenerative Medicine
Headquarters: Cambridge, Massachusetts, United States
Founded Date: Undisclosed
Employees Number: Undisclosed
Funding Status: N/A
Investor Type: Venture Capital
Investment Stage: Early Stage Venture, Seed
Number Of Exits: 3

Visit Website
Register and Claim Ownership